Changes in plasma phosphate during in-patient treatment of children with severe acute malnutrition: an observational

Hanifa Namusoke1, Anne-Louise Hother2, Maren Jh Rytter2

  • 1Mwanamugimu Nutrition Unit, Department of Pediatrics, Mulago Hospital, Kampala, Uganda;

Insights

Children with severe acute malnutrition (SAM) treated with phosphorus-fortified therapeutic formula (F-75) did not develop refeeding hypophosphatemia. Replacing F-75 with rice porridge for diarrhea management may adversely affect phosphate levels.

Area of Science:

  • Pediatric Nutrition
  • Micronutrient Metabolism
  • Global Health

Background:

  • Children with severe acute malnutrition (SAM) are susceptible to refeeding hypophosphatemia.
  • Recent therapeutic diets are fortified with phosphorus per United Nations (UN) specifications.
  • The effect of phosphorus-fortified diets on refeeding hypophosphatemia in SAM children is understudied.

Purpose of the Study:

  • To assess plasma phosphate (P-phosphate) concentrations and their correlates in children with SAM during treatment.
  • To identify factors associated with changes in P-phosphate levels during SAM treatment.

Main Methods:

  • Prospective observational study of 120 children (6-59 months) treated for SAM at Mulago Hospital, Uganda.
  • Plasma phosphate was measured at admission, during treatment with F-75 and F-100 formulas, and at discharge.
  • Correlates of P-phosphate levels and changes were analyzed.

Main Results:

  • Mean P-phosphate at admission was 1.04 ± 0.31 mmol/L, increasing by 0.43 mmol/L in the first 2 days of treatment.
  • Most children (79%) had their lowest P-phosphate at admission; severe hypophosphatemia was not observed.
  • Lower P-phosphate was associated with edema and elevated C-reactive protein; replacing F-75 with rice porridge reduced P-phosphate increase.

Conclusions:

  • Phosphorus-fortified F-75 formula appears to prevent refeeding hypophosphatemia in children with SAM.
  • Substituting F-75 with rice porridge to manage diarrhea may negatively impact P-phosphate concentrations.
  • Adherence to UN-specified phosphorus fortification in therapeutic diets is crucial for managing SAM.
Abstract

Related Concept Videos

Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...